LD-2 disclosure · 4th Quarter - Amendment
APOTEX CORPORATION
Client
- Description
- Generic pharmaceutical manufacturer
- Location
- Florida · United States of America
Registrant
- Description
- Government advisory firm
- Location
- Key Largo, Florida, United States of America
Lobbying activities
2 issuesManufacturing
Federal policy relating to strengthening domestic generic production and market access barriers for generic pharmaceuticals.
LobbyistsHENRY W MENN iii
Covered position (HENRY W MENN iii): Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.
TargetedSENATE · HOUSE OF REPRESENTATIVES
Defense
S. 4638- National Defense Authorization Act for Fiscal Year 2025 (NDAA) relating to generic drug procurement.
LobbyistsHENRY W MENN iii
Covered position (HENRY W MENN iii): Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.
TargetedSENATE